Skip to main content
OpenTrials

Clinical trial condition

Intestinal Diseases

Explore clinical trials studying Intestinal Diseases. Study availability and eligibility vary by location and protocol.

11,731 public trials 2,241 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Diseases trial results

Active, Not Recruiting

Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

NCT05817942

Conditions
Colitis, Colitis, Ulcerative, Colonic Diseases, +6 more
Locations
  • LKH - Universitätsklinikum Graz Graz, Austria
  • Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria
  • KH der Barmherzigen Brüder St.Veit an der Glan Sankt Veit an der Glan, Austria
  • AKH - Medizinische Universität Wien Vienna, Austria
View all 81 locations
View Trial Details
Active, Not Recruiting

Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy.

NCT03869892

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Centro de Oncología e Investigación de Buenos Aires COIBA Berazategui, Argentina
  • Hospital de Gastroenterología Dr. Carlos Borino Udaondo Oncology Unit Buenos Aires, Argentina
  • Fundación Favaloro Oncology Unit Buenos Aires, Argentina
  • Instituto Alexander Fleming Buenos Aires, Argentina
View all 190 locations
View Trial Details
Active, Not Recruiting

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

NCT04579380

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Breast Diseases, +37 more
Locations
  • HonorHealth Phoenix, Arizona, United States
  • HonorHealth Tempe, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope at Huntington Beach Huntington Beach, California, United States
View all 106 locations
View Trial Details
Active, Not Recruiting

An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib

NCT02955940

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +25 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • University of Louisville Louisville, Kentucky, United States
  • New York Oncology Hematology Pc. Clifton Park, New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions